Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 1/20 | 0.56 |
| ▸ | ITGB3 | P05106 | 2/20 | 0.54 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.54 |
| ▸ | MME | P08473 | 1/20 | 0.52 |
| ▸ | ACE | P12821 | 5/20 | 0.52 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.51 |
| ▸ | CTSC | P53634 | 2/20 | 0.50 |
| ▸ | ECE1 | P42892 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16983210 | 1.00 | MMP2 (0.56) | MMP2ITGB3ITGA2BMMEACE | |
| SCHEMBL2032501 | 1.00 | MMP2 (0.56) | MMP2ITGB3ITGA2BMMEACE | |
| SCHEMBL29630808 | 0.99 | MMP2 (0.55) | MMP2ITGB3ITGA2BMMEACE | |
| SCHEMBL30051999 | 0.95 | CTSB (0.55) | MMP2ITGB3ITGA2BMMEACE | |
| SCHEMBL30051480 | 0.95 | CTSB (0.55) | MMP2ITGB3ITGA2BMMEACE | |
| SCHEMBL23142823 | 0.95 | CTSB (0.55) | MMP2ITGB3ITGA2BMMEACE | |
| SCHEMBL23142822 | 0.95 | CTSB (0.55) | MMP2ITGB3ITGA2BMMEACE | |
| SCHEMBL30997458 | 0.91 | QRFPR (0.54) | MMP2ITGB3ITGA2BMME | |
| SCHEMBL30439820 | 0.91 | OPRD1 (0.52) | ITGB3ITGA2BMMECTSCLMNA | |
| SCHEMBL30439797 | 0.91 | OPRD1 (0.52) | ITGB3ITGA2BMMECTSCLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2995 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260137795-A1 | EXATECAN IMMUNOCONJUGATES | IMMUNOME INC (US) | 2026-05-21 | — | — | US | claimed |
| US-12622975-B2 | Peptide-conjugated prodrugs | BRANDEIS UNIVERSITY (US) | 2026-05-12 | — | — | US | claimed |
| US-20260077056-A1 | LINKER-PAYLOAD COMPOUND, CONJUGATES AND APPLICATIONS THEREOF | GENEQUANTUM HEALTHCARE SUZHOU CO LTD (CN) | 2026-03-19 | — | — | US | claimed |
| EP-4695258-A1 | BENZOPORPHYRIN ANALOGS, CONJUGATES, AND METHODS OF USE THEREOF | Nira Biosciences, Inc. (US) | 2026-02-18 | — | — | EP | claimed |
| EP-4684807-A1 | LINKER AND USE THEREOF IN LIGAND DRUG CONJUGATE | Duality Biologics (Shanghai) Co., Ltd. (CN) | 2026-01-28 | — | — | EP | claimed |
| EP-4684805-A1 | SELECTIVE ANTIBODY-DRUG CONJUGATES FOR TARGETED CANCER THERAPY | Universitätsmedizin der Johannes Gutenberg-Universität Mainz (DE) | 2026-01-28 | — | — | EP | claimed |
| US-20260021193-A1 | IMMUNOCONJUGATES AND METHODS | IMMUNOME INC (US) | 2026-01-22 | — | — | US | claimed |
| EP-4655006-A2 | EXATECAN IMMUNOCONJUGATES | Immunome, Inc. (US) | 2025-12-03 | — | — | EP | claimed |
| EP-4648799-A1 | LIGAND-DRUG CONJUGATES | Sun Pharma Advanced Research Company Ltd (IN) | 2025-11-19 | — | — | EP | claimed |
| US-20250332272-A1 | PREPARATION METHOD FOR DRUG LINKER CONJUGATE AND INTERMEDIATE THEREOF | MEDILINK THERAPEUTICS SUZHOU CO LTD (CN) | 2025-10-30 | — | — | US | claimed |
| WO-2022150642-A1 | ANTI-INTERLEUKIN 36 RECEPTOR (IL-36R) THERAPY FOR HIDRADENITIS SUPPURATIVA | ANAPTYSBIO, INC. (US) | 2022-07-14 | — | — | WO | claimed |
| WO-2022150644-A1 | ANTI-INTERLEUKIN 36 RECEPTOR (IL-36R) THERAPY FOR ACNE | ANAPTYSBIO, INC. (US) | 2022-07-14 | — | — | WO | claimed |
| US-20220211863-A1 | COMPOUNDS AND CONJUGATES THEREOF | MEDIMMUNE LIMITED (GB) | 2022-07-07 | — | — | US | claimed |
| US-20220193069-A1 | CAMPTOTHECIN PEPTIDE CONJUGATES | SEAGEN INC (US) | 2022-06-23 | — | — | US | claimed |
| WO-2022112356-A1 | TREATMENT OF CANCER | INNATE PHARMA (FR) | 2022-06-02 | — | — | WO | claimed |
| WO-2022078524-A2 | SPECIFIC CONJUGATION OF AN ANTIBODY | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2022-04-21 | — | — | WO | claimed |
| WO-2022026832-A9 | ANTI-INTERLEUKIN 36 RECEPTOR (IL-36R) THERAPY FOR ICHTHYOSIS | ANAPTYSBIO, INC. (US) | 2022-03-24 | — | — | WO | claimed |
| WO-2022026832-A1 | ANTI-INTERLEUKIN 36 RECEPTOR (IL-36R) THERAPY FOR ICHTHYOSIS | ANAPTYSBIO, INC. (US) | 2022-02-03 | — | — | WO | claimed |
| WO-2022026829-A1 | ANTI-INTERLEUKIN 36 RECEPTOR (IL-36R) THERAPY FOR SKIN TOXICITY | ANAPTYSBIO, INC. (US) | 2022-02-03 | — | — | WO | claimed |
| US-20150291659-A1 | SOLOMONAMIDE ANALOGUE COMPOUNDS, PHARMACEUTICALS CONTAINING SOLOMONAMIDE ANALOGUE COMPOUNDS, AND PROCESSES FOR THE PREPARATION THEREOF | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2015-10-15 | — | — | US | claimed |